FDA SCRUTINIZES OFF-LABEL PROMOTIONS

被引：7
作者：
RANDALL, T
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 01期
关键词：
D O I：
10.1001/jama.266.1.11
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
[21]   FDA guidance on off-label promotion and the state of the literature from sponsors [J].
Psaty, Bruce M. ;
Ray, Wayne .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (16) :1949-1951
[22]   Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing [J].
Kesselheim, Aaron S. ;
Woloshin, Steven ;
Lu, Zhigang ;
Tessema, Frazer A. ;
Ross, Kathryn M. ;
Schwartz, Lisa M. .
JAMA INTERNAL MEDICINE, 2019, 179 (05) :707-709
[23]   FDA proposes mechanism for disseminating information about off-label uses [J].
不详 .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (14) :1449-1450
[24]   Application of the FDA Biosimilar Extrapolation Framework to Make Off-Label Determinations [J].
Li, Edward ;
Lobaina, Ernesto .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (12) :1227-1232
[25]   FDA warns against off-label use of ketoconazole oral tablets [J].
Reactions Weekly, 2016, 1604 (1) :3-3
[26]   Lawsuit challenges FDA's authority to prevent off-label marketing [J].
Dyer, Owen .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[27]   Judge strikes down FDA policies on industry dissemination of off-label information [J].
不详 .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (17) :1695-1696
[28]   Off-label prescription [J].
Srinivasan, S .
NATIONAL MEDICAL JOURNAL OF INDIA, 2004, 17 (04) :229-229
[29]   Off-label promotion [J].
Kuehn, BM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06) :673-673
[30]   Off-label prescribing [J].
Raknes, Guttorm .
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (04) :335-335
12345